Patents Assigned to Cenestra LLC
-
Publication number: 20130213851Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: ApplicationFiled: August 21, 2012Publication date: August 22, 2013Applicant: CENESTRA LLC.Inventors: Seth D. Feuerstein, Ann Coric, Louis C. Sanfilippo
-
Publication number: 20120172431Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: ApplicationFiled: December 5, 2011Publication date: July 5, 2012Applicant: CENESTRA LLCInventors: Seth D. Feuerstein, Ann CORIC, Louis C. Sanfilippo
-
Publication number: 20110303573Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: ApplicationFiled: June 27, 2011Publication date: December 15, 2011Applicant: CENESTRA LLCInventors: Seth D. FEUERSTEIN, Ann Coric, Louis C. Sanfilippo
-
Patent number: 8071646Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: GrantFiled: October 28, 2009Date of Patent: December 6, 2011Assignee: Cenestra LLCInventors: Seth D. Feuerstein, Ann Coric, Louis C. Sanfilippo
-
Patent number: 7869010Abstract: Methods for evaluation of fish oil, oils, omega-3 fatty acid compositions, and dietary supplements containing omega-3 essential fatty acids and other fats are provided herein. The relative purity and/or concentration of oil-containing aliquots can be determined by cooling approximately equal volumes of two or more aliquots to a temperature near or below 0 degrees Celsius. When cooled, the most opaque aliquots are the least pure. The invention also provide a method for determining whether an omega-3 fatty acid supplement is greater than 90% pure, which includes cooling the supplement to less than 0 degrees Celsius and a determining that the supplement is 90% pure if its appearance is essentially unchanged from its appearance and room temperature.Type: GrantFiled: January 23, 2009Date of Patent: January 11, 2011Assignee: Cenestra LLCInventor: Vladimir Coric
-
Publication number: 20100130611Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: ApplicationFiled: January 25, 2010Publication date: May 27, 2010Applicant: CENESTRA LLCInventors: Seth D. FEUERSTEIN, Ann Coric, Louis C. Sanfilippo
-
Publication number: 20100112047Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: ApplicationFiled: October 28, 2009Publication date: May 6, 2010Applicant: CENESTRA LLCInventors: Seth D. FEUERSTEIN, Ann Coric, Louis C. Sanfitippo
-
Patent number: 7652068Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: GrantFiled: December 20, 2006Date of Patent: January 26, 2010Assignee: Cenestra LLCInventors: Seth Feuerstein, Ann Coric, Louis C. Sanfilippo
-
Publication number: 20080268042Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: ApplicationFiled: July 9, 2008Publication date: October 30, 2008Applicant: CENESTRA LLCInventors: Seth D. Feuerstein, Ann Coric, Louis C. Sanfilippo
-
Publication number: 20070141138Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.Type: ApplicationFiled: December 20, 2006Publication date: June 21, 2007Applicant: CENESTRA LLCInventors: Seth Feuerstein, Ann Coric, Louis Sanfilippo